Evidence map›Paper›PMID 32727045›Full record

ArticleInternational journal of molecular sciences2020

miR-365 (microRNA): Potential Biomarker in Oral Squamous Cell Carcinoma Exosomes and Extracellular Vesicles.

Jeffery Coon, Karl Kingsley, Katherine M Howard

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Emerging roles of exosomes in oral diseases progression.International journal of oral science · 2024
    Review
  8. Review
  9. Review
  10. Potassium Channels, Glucose Metabolism and Glycosylation in Cancer Cells.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jeffery CoonDepartment of Clinical Sciences, Las Vegas-School of Dental Medicine, University of Nevada, 1001 Shadow Lane, Las Vegas, NV 89106, USA.
Karl KingsleyDepartment of Biomedical Sciences and Director of Student Research, Las Vegas-School of Dental Medicine, University of Nevada, 1001 Shadow Lane, Las Vegas, NV 89106, USA.ORCID 0000-0002-1036-7522
Katherine M HowardDepartment of Biomedical Sciences, Las Vegas-School of Dental Medicine, University of Nevada, 1001 Shadow Lane, Las Vegas, NV 89106, USA.
University of Nevada, Las Vegas · US

Funding

P. gingivalis Polarizes Aberrant M1 MacrophagesR15DE028431 · NIDCR · UNIVERSITY OF NEVADA LAS VEGAS · PI EBERSOLE, JEFFREY L · 2019 to 2019
$448k
NIDCR NIH HHS R15 DE028431
6 · The paper itself

Abstract

introductionmiR-365 is a non-coding microRNA that regulates transcription and has been demonstrated to promote oncogenesis and metastasis in some cancers, while suppressing these effects in others. Many microRNAs are produced and then exported extracellularly in exosomes, which are small extracellular vesicles ranging from 30 to 100 nm that are found in eukaryotic fluids and facilitate many cellular functions. Exosomes and extracellular vesicles are produced by many cell types, including oral cancer cells-although no study to date has evaluated miR-365 and oral cancer exosomes or extracellular vesicles. Based on this information, our research question was to evaluate whether oral cancers produce exosomes or extracellular vesicles containing miR-365. MATERIALS AND

methodsTwo commercially available oral cancer cell lines (SCC25 and CAL27) and a normal oral keratinocyte (OKF4) were grown in serum-free media, supplemented with exosome-depleted fetal bovine serum. Extracellular vesicles and exosomes were then isolated using the Invitrogen total exosome RNA and protein isolation kit for processing using the hsa-miR-365a-5p microRNA qPCR assay kit.

resultsRNA was successfully isolated from the exosome-depleted supernatant from each cell line-SCC9, SCC15, SCC25, and CAL27 (oral squamous cell carcinomas) and OKF4 (oral epithelial cell line). Relative concentrations of RNA were similar among each cell line, which were not significantly different,

conclusionsThese results confirm that miR-365 is not only expressed in oral cancer cell lines, but also is subsequently exported into exosomes and extracellular vesicles derived from these cultures. These data may help to contextualize the potential for this microRNA to contribute to the phenotypes and behaviors of oral cancers that express this microRNA. Future research will begin to investigate these potential mechanisms and pathways and to determine if miR-365 may be useful as an oral cancer biomarker for salivary or liquid biopsies.

Indexed as

Biomarkers, TumorExosomesHead and Neck NeoplasmsMicroRNAsRNA, NeoplasmSquamous Cell Carcinoma of Head and NeckCell Line, TumorHumansBiomarkers, TumorMicroRNAsMIRN365 microRNA, humanRNA, Neoplasmexosomeextracellular vesicleliquid biopsymicroRNAmiR-365oral cancer

Identifiers

PMID32727045
PMCPMC7432426
OpenAlexW3043992795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.